Browsing by Author "Allan K."

Now showing 1 - 3 of 3
  • No Thumbnail Available
    Item
    Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
    (International Union Against Tuberculosis and Lung Disease, 2022) Stolbrink M.; Chinouya M.J.; Jayasooriya S.; Nightingale R.; Evans-Hill L.; Allan K.; Allen H.; Balen J.; Beacon T.; Bissell K.; Chakaya J.; Chiang C-Y.; Cohen M.; Devereux G.; El Sony A.; Halpin D.M.G.; Hurst J.R.; Kiprop C.; Lawson A.; Macé C.; Makhanu A.; Makokha P.; Masekela R.; Meme H.; Khoo E.M.; Nantanda R.; Pasternak S.; Perrin C.; Reddel H.; Rylance S.; Schweikert P.; Were C.; Williams S.; Winders T.; Yorgancioglu A.; Marks G.B.; Mortimer K.
    BACKGROUND: Access to affordable inhaled medicines for chronic respiratory diseases (CRDs) is severely limited in low- and middle-income countries (LMICs), causing avoidable morbidity and mortality. The International Union Against Tuberculosis and Lung Disease convened a stakeholder meeting on this topic in February 2022. METHODS : Focused group discussions were informed by literature and presentations summarising experiences of obtaining inhaled medicines in LMICs. The virtual meeting was moderated using a topic guide around barriers and solutions to improve access. The thematic framework approach was used for analysis. RESULT S : A total of 58 key stakeholders, including patients, healthcare practitioners, members of national and international organisations, industry and WHO representatives attended the meeting. There were 20 pre-meeting material submissions. The main barriers identified were 1) low awareness of CRDs; 2) limited data on CRD burden and treatments in LMICs; 3) ineffective procurement and distribution networks; and 4) poor communication of the needs of people with CRDs. Solutions discussed were 1) generation of data to inform policy and practice; 2) capacity building; 3) improved procurement mechanisms; 4) strengthened advocacy practices; and 5) a World Health Assembly Resolution. CONC L U S ION: There are opportunities to achieve improved access to affordable, quality-assured inhaled medicines in LMICs through coordinated, multi-stakeholder, collaborative efforts. © 2022 International Union against Tubercul. and Lung Dis.. All rights reserved.
  • No Thumbnail Available
    Item
    Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective
    (Elsevier B.V., 2023) Levy M.L.; Bateman E.D.; Allan K.; Bacharier L.B.; Bonini M.; Boulet L.-P.; Bourdin A.; Brightling C.; Brusselle G.; Buhl R.; Chakaya M.J.; Cruz A.A.; Drazen J.; Ducharme F.M.; Duijts L.; Fleming L.; Inoue H.; Ko F.W.S.; Krishnan J.A.; Masekela R.; Mortimer K.; Pitrez P.; Salvi S.; Sheikh A.; Reddel H.K.; Yorgancıoğlu A.
    [No abstract available]
  • No Thumbnail Available
    Item
    Global initiative for asthma: 30 years of promoting evidence-based asthma care
    (John Wiley and Sons Inc, 2023) Yorgancıoğlu A.; Reddel H.K.; Allan K.; Bateman E.D.; Brusselle G.; Chakaya M.J.; Cruz A.A.; Inoue H.; Krishnan J.A.; Levy M.L.; Reddel H.K.; Bacharier L.; Bonini M.; Boulet L.-P.; Bourdin A.; Brightling C.; Buhl R.; Drazen J.; Ducharme F.; Duijts L.; Fleming L.; Ko F.W.S.; Masekela R.; Mortimer K.; Pitrez P.; Sheikh A.; Salvi S.
    [No abstract available]